Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial - Maynard, G; Kannan, R; Liu, J (Lancet Neurol, 2023)
et al.